Aethlon Medical Inc
AEMDStockNASDAQ
$2.02 ▲ +6.32%
12 juin 2026
A
Aethlon Medical Inc
$2.02 ▲ +6.32%
12 juin 2026
AEMDStockNASDAQ

01 / À propos

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Arberion
Loading market data